{"id":76799,"date":"2026-11-03T19:26:00","date_gmt":"2026-11-03T19:26:00","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76799"},"modified":"2026-11-03T20:00:19","modified_gmt":"2026-11-03T20:00:19","slug":"american-analyst-updates-nov-2nd-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/","title":{"rendered":"American  Analyst Updates: Nov 2nd, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76799&amp;preview=true\"><strong>Analyst Ratings (USA)<\/strong><\/a><\/h2>\n<p>Today&#8217;s analyst updates for November 2nd, \u00a0show the clearest optimism in energy and healthcare, with multiple price-target increases for major oil producers and large pharmaceutical companies. Consumer staples also saw target increases, though neutral ratings remained common. Technology was mixed, with selective upside in semiconductors alongside downgrades and target cuts across parts of software and digital assets.<\/p>\n<h3>Updates (523)<\/h3>\n<p data-pm-slice=\"1 1 []\"><strong>AbbVie (ABBV)<\/strong> \u2014 Canaccord Genuity raises its price target to $338.00 from $290.00, maintaining a Buy rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $325.00 from $290.00, maintaining an Overweight rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Guggenheim raises its price target to $322.00 from $288.00, maintaining a Buy rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Leerink Partners raises its price target to $342.00 from $309.00, maintaining an Outperform rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Morgan Stanley raises its price target to $346.00 from $310.00, maintaining an Overweight rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 RBC Capital raises its price target to $330.00 from $280.00, maintaining an Outperform rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Sanford C. Bernstein reiterates its Market Perform rating with a $275.00 price target.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 UBS raises its price target to $295.00 from $275.00, maintaining a Neutral rating.<\/p>\n<p><strong>AbbVie (ABBV)<\/strong> \u2014 Wells Fargo raises its price target to $340.00 from $300.00, maintaining an Overweight rating.<\/p>\n<p><strong>Acumen Pharmaceuticals (ABOS)<\/strong> \u2014 BofA Securities downgrades the stock from Buy to Underperform with a $1.00 price target.<\/p>\n<p><strong>Acumen Pharmaceuticals (ABOS)<\/strong> \u2014 BTIG Research lowers its price target to $1.00, maintaining a Buy rating.<\/p>\n<p><strong>Advanced Micro Devices (AMD)<\/strong> \u2014 Morgan Stanley raises its price target to $510.00 from $465.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Aeluma (ALMU)<\/strong> \u2014 Northland Securities initiates coverage with an Outperform rating with a $16.00 price target.<\/p>\n<p><strong>AeroVironment (AVAV)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n<p><strong>AeroVironment (AVAV)<\/strong> \u2014 KeyCorp lowers its price target to $200.00 from $220.00, maintaining an Overweight rating.<\/p>\n<p><strong>AGCO (AGCO)<\/strong> \u2014 Truist reiterates its Buy rating with a $136.00 price target.<\/p>\n<p><strong>Agnico Eagle Mines (AEM)<\/strong> \u2014 Barclays PLC lowers its price target to $215.00 from $218.00, maintaining an Overweight rating.<\/p>\n<p><strong>Agnico Eagle Mines (AEM)<\/strong> \u2014 Freedom Broker upgrades the stock from Hold to Buy with a $212.00 price target.<\/p>\n<p><strong>Akamai Technologies (AKAM)<\/strong> \u2014 Morgan Stanley lowers its price target to $149.00 from $165.00, maintaining an Overweight rating.<\/p>\n<p><strong>Alaska Air Group (ALK)<\/strong> \u2014 UBS lowers its price target to $48.00 from $51.00, maintaining a Buy rating.<\/p>\n<p><strong>Alignment Healthcare (ALHC)<\/strong> \u2014 TD Cowen lowers its price target to $10.00 from $12.00, maintaining a Buy rating.<\/p>\n<p><strong>Alliant Energy (LNT)<\/strong> \u2014 Wells Fargo raises its price target to $82.00 from $81.00, maintaining an Overweight rating.<\/p>\n<p><strong>Ally Financial (ALLY)<\/strong> \u2014 UBS lowers its price target to $48.00 from $50.00, maintaining a Buy rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Barclays PLC lowers its price target to $380.00 from $450.00, maintaining an Overweight rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Canaccord Genuity lowers its price target to $323.00 from $429.00, maintaining a Buy rating.<\/p>\n<p><strong>Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 Truist downgrades the stock from Buy to Hold with a $225.00 price target.<\/p>\n<p><strong>Alphabet (GOOG)<\/strong> \u2014 Wells Fargo sets a $365.00 price target.<\/p>\n<p><strong>Altria Group (MO)<\/strong> \u2014 Barclays PLC raises its price target to $60.00 from $58.00, maintaining an Underweight rating.<\/p>\n<p><strong>Amazon.com (AMZN)<\/strong> \u2014 Phillip Securities upgrades the stock from Moderate Buy to Strong-Buy.<\/p>\n<p><strong>Ambiq Micro (AMBQ)<\/strong> \u2014 UBS lowers its price target to $50.00 from $73.00, maintaining a Neutral rating.<\/p>\n<p><strong>Amerant Bancorp (AMTB)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterates its Market Perform rating.<\/p>\n<p><strong>American Electric Power (AEP)<\/strong> \u2014 Barclays PLC raises its price target to $132.00 from $120.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>American Express (AXP)<\/strong> \u2014 UBS raises its price target to $346.00 from $345.00, maintaining a Neutral rating.<\/p>\n<p><strong>Amphenol (APH)<\/strong> \u2014 Barclays PLC raises its price target to $111.00 from $100.00, maintaining an Overweight rating.<\/p>\n<p><strong>Amphenol (APH)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating with a $102.00 price target.<\/p>\n<p><strong>Amrize (AMRZ)<\/strong> \u2014 Oppenheimer Holdings, Inc. lowers its price target to $52.00 from $55.00, maintaining an Outperform rating.<\/p>\n<p><strong>AngloGold Ashanti (AU)<\/strong> \u2014 TD Cowen initiates coverage with a Buy rating with a $123.00 price target.<\/p>\n<p><strong>AngloGold Ashanti (AU)<\/strong> \u2014 TD Securities initiates coverage with a Strong-Buy rating.<\/p>\n<p><strong>Antero Midstream (AM)<\/strong> \u2014 Wells Fargo raises its price target to $25.00 from $24.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>AON (AON)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $410.00 from $400.00, maintaining an Overweight rating.<\/p>\n<p><strong>AON (AON)<\/strong> \u2014 Raymond James upgrades the stock from Underperform to Market Perform.<\/p>\n<p><strong>AON (AON)<\/strong> \u2014 UBS lowers its price target to $356.00 from $387.00, maintaining a Neutral rating.<\/p>\n<p><strong>AON (AON)<\/strong> \u2014 Wells Fargo raises its price target to $364.00 from $323.00, maintaining an Overweight rating.<\/p>\n<p><strong>Applied Optoelectronics (AAOI)<\/strong> \u2014 Northland Securities upgrades the stock from Market Perform to Outperform with a $120.00 price target.<\/p>\n<p><strong>AptarGroup (ATR)<\/strong> \u2014 BofA Securities reiterates its Buy rating.<\/p>\n<p><strong>Arch Capital Group (ACGL)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $111.00 from $105.00, maintaining a Neutral rating.<\/p>\n<p><strong>Arch Capital Group (ACGL)<\/strong> \u2014 UBS raises its price target to $125.00 from $120.00, maintaining a Buy rating.<\/p>\n<p><strong>Arch Capital Group (ACGL)<\/strong> \u2014 Wells Fargo raises its price target to $119.00 from $107.00, maintaining an Overweight rating.<\/p>\n<p><strong>Arista Networks (ANET)<\/strong> \u2014 Evercore Inc reiterates its Outperform rating.<\/p>\n<p><strong>Arista Networks (ANET)<\/strong> \u2014 Wells Fargo sets a $250.00 price target.<\/p>\n<p><strong>Arthur J. Gallagher &amp; Co. (AJG)<\/strong> \u2014 Citigroup downgrades the stock from Buy to Neutral with a $300.00 price target.<\/p>\n<p><strong>Arthur J. Gallagher &amp; Co. (AJG)<\/strong> \u2014 UBS raises its price target to $320.00 from $299.00, maintaining a Buy rating.<\/p>\n<p><strong>Arthur J. Gallagher &amp; Co. (AJG)<\/strong> \u2014 Wells Fargo raises its price target to $312.00 from $284.00, maintaining an Overweight rating.<\/p>\n<p><strong>Atlassian (TEAM)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $252.00 from $220.00, maintaining an Overweight rating.<\/p>\n<p><strong>Aurinia Pharmaceuticals (AUPH)<\/strong> \u2014 RBC Capital raises its price target to $18.00 from $16.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Autolus Therapeutics (AUTL)<\/strong> \u2014 HC Wainwright initiates coverage with a Buy rating.<\/p>\n<p><strong>Avery Dennison (AVY)<\/strong> \u2014 Citigroup raises its price target to $191.00 from $186.00, maintaining a Neutral rating.<\/p>\n<p><strong>Avis Budget Group (CAR)<\/strong> \u2014 Barclays PLC lowers its price target to $115.00 from $160.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Axalta Coating Systems (AXTA)<\/strong> \u2014 RBC Capital lowers its price target to $35.00 from $36.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Axis Capital (AXS)<\/strong> \u2014 Mizuho sets a $123.00 price target.<\/p>\n<p><strong>Axis Capital (AXS)<\/strong> \u2014 Wells Fargo raises its price target to $122.00 from $112.00, maintaining an Overweight rating.<\/p>\n<p><strong>Axon Enterprise (AXON)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n<p><strong>Bank of America (BAC)<\/strong> \u2014 UBS lowers its price target to $62.00 from $67.00, maintaining a Buy rating.<\/p>\n<p><strong>Bank of Hawaii (BOH)<\/strong> \u2014 Stephens lowers its price target to $76.00 from $82.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Bank of Marin Bancorp (BMRC)<\/strong> \u2014 Stephens raises its price target to $33.00 from $30.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Bausch + Lomb (BLCO)<\/strong> \u2014 HC Wainwright downgrades the stock from Buy to Neutral with a $22.00 price target.<\/p>\n<p><strong>Benitec Biopharma (BNTC)<\/strong> \u2014 HC Wainwright reiterates its Buy rating.<\/p>\n<p><strong>Biogen (BIIB)<\/strong> \u2014 Guggenheim raises its price target to $300.00 from $280.00, maintaining a Buy rating.<\/p>\n<p><strong>Biogen (BIIB)<\/strong> \u2014 HC Wainwright raises its price target to $270.00 from $251.00, maintaining a Buy rating.<\/p>\n<p><strong>Bloomin&#8217; Brands (BLMN)<\/strong> \u2014 UBS raises its price target to $11.50 from $9.00, maintaining a Neutral rating.<\/p>\n<p><strong>Blue Owl Capital (OWL)<\/strong> \u2014 Piper Sandler raises its price target to $13.00 from $12.00, maintaining an Overweight rating.<\/p>\n<p><strong>Blue Owl Capital (OWL)<\/strong> \u2014 Goldman Sachs raises its price target to $10.50 from $9.50, maintaining a Neutral rating.<\/p>\n<p><strong>BorgWarner (BWA)<\/strong> \u2014 Barclays PLC lowers its price target to $80.00 from $85.00, maintaining an Overweight rating.<\/p>\n<p><strong>BP (BP)<\/strong> \u2014 Wells Fargo raises its price target to $63.00 from $57.00, maintaining an Overweight rating.<\/p>\n<p><strong>Bread Financial (BFH)<\/strong> \u2014 UBS lowers its price target to $120.00 from $127.00, maintaining a Buy rating.<\/p>\n<p><strong>BridgeBio Pharma (BBIO)<\/strong> \u2014 Canaccord Genuity raises its price target to $108.00 from $106.00, maintaining a Buy rating.<\/p>\n<p><strong>Bright Horizons Family Solutions (BFAM)<\/strong> \u2014 Barclays PLC lowers its price target to $80.00 from $95.00, maintaining an Overweight rating.<\/p>\n<p><strong>Bright Minds Biosciences (DRUG)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a $37.00 price target.<\/p>\n<p><strong>Bright Minds Biosciences (DRUG)<\/strong> \u2014 Jefferies reiterates its Buy rating.<\/p>\n<p><strong>BrightSpring Health Services (BTSG)<\/strong> \u2014 Leerink Partners raises its price target to $92.00 from $72.00, maintaining an Outperform rating.<\/p>\n<p><strong>BrightSpring Health Services (BTSG)<\/strong> \u2014 TD Cowen raises its price target to $84.00 from $81.00, maintaining a Buy rating.<\/p>\n<p><strong>BrightSpring Health Services (BTSG)<\/strong> \u2014 Goldman Sachs reiterates its Buy rating with a $90.00 price target.<\/p>\n<p><strong>BrightSpring Health Services (BTSG)<\/strong> \u2014 UBS raises its price target to $92.00 from $85.00, maintaining a Buy rating.<\/p>\n<p><strong>BrightSpring Health Services (BTSG)<\/strong> \u2014 Wells Fargo raises its price target to $82.00 from $78.00, maintaining an Overweight rating.<\/p>\n<p><strong>British American Tobacco (BTI)<\/strong> \u2014 Goldman Sachs upgrades the stock from Neutral to Buy.<\/p>\n<p><strong>Brixmor Property Group (BRX)<\/strong> \u2014 Citigroup lowers its price target to $32.00 from $34.00, maintaining a Neutral rating.<\/p>\n<p><strong>Broadstone Net Lease (BNL)<\/strong> \u2014 Goldman Sachs lowers its price target to $23.00 from $26.00, maintaining a Buy rating.<\/p>\n<p><strong>Brown &amp; Brown (BRO)<\/strong> \u2014 UBS lowers its price target to $72.00 from $73.00, maintaining a Neutral rating.<\/p>\n<p><strong>Brunswick (BC)<\/strong> \u2014 Citigroup lowers its price target to $93.00 from $101.00, maintaining a Buy rating.<\/p>\n<p><strong>Builders FirstSource (BLDR)<\/strong> \u2014 Stifel Nicolaus raises its price target to $58.00 from $55.00, maintaining a Hold rating.<\/p>\n<p><strong>C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 Susquehanna lowers its price target to $166.00 from $180.00, maintaining a Positive rating.<\/p>\n<p><strong>C4 Therapeutics (CCCC)<\/strong> \u2014 Evercore Inc downgrades the stock from Strong-Buy to Hold.<\/p>\n<p><strong>Cameco (CCJ)<\/strong> \u2014 Barclays PLC lowers its price target to $89.00 from $95.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Camtek (CAMT)<\/strong> \u2014 Morgan Stanley downgrades the stock from Equal Weight to Underweight with a $126.00 price target.<\/p>\n<p><strong>Canadian National Railway (CNI)<\/strong> \u2014 Barclays PLC raises its price target to $132.00 from $130.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Canadian National Railway (CNI)<\/strong> \u2014 Citigroup raises its price target to $145.00 from $143.00, maintaining a Buy rating.<\/p>\n<p><strong>Capital One Financial (COF)<\/strong> \u2014 UBS lowers its price target to $274.00 from $280.00, maintaining a Buy rating.<\/p>\n<p><strong>Capri (CPRI)<\/strong> \u2014 Barclays PLC raises its price target to $24.00 from $19.00, maintaining an Overweight rating.<\/p>\n<p><strong>Capri (CPRI)<\/strong> \u2014 Goldman Sachs raises its price target to $20.00 from $18.00, maintaining a Neutral rating.<\/p>\n<p><strong>Capri (CPRI)<\/strong> \u2014 UBS raises its price target to $19.00 from $17.00, maintaining a Neutral rating.<\/p>\n<p><strong>Capri (CPRI)<\/strong> \u2014 Wells Fargo raises its price target to $18.00 from $16.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Carrier Global (CARR)<\/strong> \u2014 Robert W. Baird lowers its price target to $70.00 from $72.00, maintaining an Outperform rating.<\/p>\n<p><strong>Carter&#8217;s (CRI)<\/strong> \u2014 BofA Securities lowers its price target to $28.00 from $30.00, maintaining an Underperform rating.<\/p>\n<p><strong>Carter&#8217;s (CRI)<\/strong> \u2014 UBS lowers its price target to $33.00 from $38.00, maintaining a Neutral rating.<\/p>\n<p><strong>Caterpillar (CAT)<\/strong> \u2014 DA Davidson lowers its price target to $685.00 from $882.00, maintaining a Neutral rating.<\/p>\n<p><strong>Caterpillar (CAT)<\/strong> \u2014 Freedom Broker lowers its price target to $800.00 from $980.00, maintaining a Buy rating.<\/p>\n<p><strong>Cavco Industries (CVCO)<\/strong> \u2014 Oppenheimer Holdings, Inc. reiterates its Outperform rating with a $735.00 price target.<\/p>\n<p><strong>Centene (CNC)<\/strong> \u2014 Truist reiterates its Buy rating with a $82.00 price target.<\/p>\n<p><strong>Cerebras Systems (CBRS)<\/strong> \u2014 UBS lowers its price target to $250.00 from $330.00, maintaining a Buy rating.<\/p>\n<p><strong>Ceva (CEVA)<\/strong> \u2014 UBS lowers its price target to $40.00 from $48.00, maintaining a Buy rating.<\/p>\n<p><strong>CF Industries (CF)<\/strong> \u2014 Freedom Broker lowers its price target to $129.00 from $133.00, maintaining a Hold rating.<\/p>\n<p><strong>CF Industries (CF)<\/strong> \u2014 Truist sets a $129.00 price target.<\/p>\n<p><strong>Check Point Software Technologies (CHKP)<\/strong> \u2014 Stifel Nicolaus sets a $148.00 price target.<\/p>\n<p><strong>Cheniere Energy (LNG)<\/strong> \u2014 Wolfe Research downgrades the stock from Outperform to Peer Perform.<\/p>\n<p><strong>Chevron (CVX)<\/strong> \u2014 Barclays PLC raises its price target to $244.00 from $208.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Chevron (CVX)<\/strong> \u2014 Morgan Stanley raises its price target to $230.00 from $226.00, maintaining an Overweight rating.<\/p>\n<p><strong>Chevron (CVX)<\/strong> \u2014 UBS raises its price target to $265.00 from $235.00, maintaining a Buy rating.<\/p>\n<p><strong>Chevron (CVX)<\/strong> \u2014 Wells Fargo raises its price target to $268.00 from $230.00, maintaining an Overweight rating.<\/p>\n<p><strong>ChoiceOne Financial Services (COFS)<\/strong> \u2014 DA Davidson raises its price target to $40.00 from $38.00, maintaining a Buy rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Citigroup raises its price target to $110.00 from $105.00, maintaining a Neutral rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 JPMorgan raises its price target to $109.00 from $105.00, maintaining a Neutral rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Morgan Stanley raises its price target to $117.00 from $112.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 UBS raises its price target to $112.00 from $106.00, maintaining a Neutral rating.<\/p>\n<p><strong>Church &amp; Dwight (CHD)<\/strong> \u2014 Wells Fargo reiterates its Overweight rating with a $115.00 price target.<\/p>\n<p><strong>Cimpress (CMPR)<\/strong> \u2014 Truist lowers its price target to $90.00 from $108.00, maintaining a Buy rating.<\/p>\n<p><strong>Cinemark (CNK)<\/strong> \u2014 Morgan Stanley raises its price target to $45.00 from $40.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Cipher Mining (CIFR)<\/strong> \u2014 HC Wainwright reiterates its Buy rating.<\/p>\n<p><strong>Circle Internet Group (CRCL)<\/strong> \u2014 Morgan Stanley lowers its price target to $34.00 from $37.00, maintaining an Underweight rating.<\/p>\n<p><strong>Clean Harbors (CLH)<\/strong> \u2014 Citigroup raises its price target to $379.00 from $378.00, maintaining a Buy rating.<\/p>\n<p><strong>Clorox (CLX)<\/strong> \u2014 Evercore Inc upgrades the stock from Underperform to Hold with a $99.00 price target.<\/p>\n<p><strong>Cloudflare (NET)<\/strong> \u2014 Jefferies lowers its price target to $320.00 from $350.00, maintaining a Hold rating.<\/p>\n<p><strong>Cognizant Technology Solutions (CTSH)<\/strong> \u2014 Mizuho sets a $69.00 price target.<\/p>\n<p><strong>Coinbase Global (COIN)<\/strong> \u2014 Morgan Stanley downgrades the stock from Equal Weight to Underweight with a $120.00 price target.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 BofA Securities raises its price target to $105.00 from $100.00, maintaining a Buy rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 BNP Paribas Exane reiterates its Outperform rating with a $108.00 price target.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 JPMorgan lowers its price target to $102.00 from $104.00, maintaining an Overweight rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 Morgan Stanley raises its price target to $111.00 from $104.00, maintaining an Overweight rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 RBC Capital raises its price target to $105.00 from $104.00, maintaining an Outperform rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 TD Cowen raises its price target to $97.00 from $90.00, maintaining a Hold rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 UBS raises its price target to $112.00 from $106.00, maintaining a Buy rating.<\/p>\n<p><strong>Colgate-Palmolive (CL)<\/strong> \u2014 Wells Fargo raises its price target to $95.00 from $90.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>ConocoPhillips (COP)<\/strong> \u2014 Raymond James reiterates its Outperform rating with a $170.00 price target.<\/p>\n<p><strong>ConocoPhillips (COP)<\/strong> \u2014 UBS reiterates its Outperform rating.<\/p>\n<p><strong>Constellation Brands (STZ)<\/strong> \u2014 Jefferies reiterates its Hold rating with a $142.00 price target.<\/p>\n<p><strong>CorMedix (CRMD)<\/strong> \u2014 Needham &amp; Company LLC lowers its price target to $12.00 from $15.00, maintaining a Buy rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 Citigroup raises its price target to $108.00 from $106.00, maintaining a Buy rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 DA Davidson lowers its price target to $114.00 from $117.00, maintaining a Buy rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 Stephens raises its price target to $110.00 from $105.00, maintaining an Overweight rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 Truist raises its price target to $120.00 from $105.00, maintaining a Buy rating.<\/p>\n<p><strong>CRH (CRH)<\/strong> \u2014 UBS reiterates its Buy rating.<\/p>\n<p><strong>CSW Industrials (CSW)<\/strong> \u2014 Truist lowers its price target to $328.00 from $332.00, maintaining a Hold rating.<\/p>\n<p><strong>Cullen\/Frost Bankers (CFR)<\/strong> \u2014 Keefe, Bruyette &amp; Woods downgrades the stock from Outperform to Market Perform with a $175.00 price target.<\/p>\n<p><strong>Curbline Properties (CURB)<\/strong> \u2014 Truist raises its price target to $34.00 from $33.00, maintaining a Buy rating.<\/p>\n<p><strong>D-Wave Quantum (QBTS)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $27.00 from $40.00, maintaining a Buy rating.<\/p>\n<p><strong>D.R. Horton (DHI)<\/strong> \u2014 Citigroup raises its price target to $152.00 from $150.00, maintaining a Neutral rating.<\/p>\n<p><strong>Dana (DAN)<\/strong> \u2014 Barclays PLC lowers its price target to $33.00 from $35.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Datadog (DDOG)<\/strong> \u2014 Evercore Inc reiterates its Outperform rating with a $300.00 price target.<\/p>\n<p><strong>DaVita (DVA)<\/strong> \u2014 Barclays PLC lowers its price target to $216.00 from $224.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>DaVita (DVA)<\/strong> \u2014 TD Cowen raises its price target to $228.00 from $220.00, maintaining a Buy rating.<\/p>\n<p><strong>DaVita (DVA)<\/strong> \u2014 UBS raises its price target to $287.00 from $270.00, maintaining a Buy rating.<\/p>\n<p><strong>Docebo (DCBO)<\/strong> \u2014 Oppenheimer Holdings, Inc. raises its price target to $35.00 from $25.00, maintaining an Outperform rating.<\/p>\n<p><strong>Dominion Energy (D)<\/strong> \u2014 Mizuho sets a $68.00 price target.<\/p>\n<p><strong>Donnelley Financial Solutions (DFIN)<\/strong> \u2014 DA Davidson raises its price target to $76.00 from $62.00, maintaining a Buy rating.<\/p>\n<p><strong>DraftKings (DKNG)<\/strong> \u2014 Needham &amp; Company LLC lowers its price target to $30.00 from $35.00, maintaining a Buy rating.<\/p>\n<p><strong>Duolingo (DUOL)<\/strong> \u2014 Evercore Inc reiterates its Outperform rating.<\/p>\n<p><strong>DXC Technology (DXC)<\/strong> \u2014 Morgan Stanley raises its price target to $12.00 from $9.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>EastGroup Properties (EGP)<\/strong> \u2014 Wells Fargo raises its price target to $236.00 from $232.00, maintaining an Overweight rating.<\/p>\n<p><strong>Eastman Chemical (EMN)<\/strong> \u2014 Barclays PLC raises its price target to $74.00 from $72.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Eastman Chemical (EMN)<\/strong> \u2014 JPMorgan lowers its price target to $65.00 from $66.00, maintaining a Neutral rating.<\/p>\n<p><strong>Eastman Chemical (EMN)<\/strong> \u2014 Goldman Sachs reiterates its Neutral rating with a $72.00 price target.<\/p>\n<p><strong>Edison International (EIX)<\/strong> \u2014 Mizuho sets a $63.00 price target.<\/p>\n<p><strong>Eli Lilly and Company (LLY)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $1,600.00 from $1,440.00, maintaining an Overweight rating.<\/p>\n<p><strong>EMCOR Group (EME)<\/strong> \u2014 Cantor Fitzgerald lowers its price target to $920.00 from $1,047.00, maintaining an Overweight rating.<\/p>\n<p><strong>EMCOR Group (EME)<\/strong> \u2014 Oppenheimer Holdings, Inc. lowers its price target to $1,000.00 from $1,200.00, maintaining an Outperform rating.<\/p>\n<p><strong>Encompass Health (EHC)<\/strong> \u2014 Mizuho sets a $155.00 price target.<\/p>\n<p><strong>Enterprise Products Partners (EPD)<\/strong> \u2014 Goldman Sachs reiterates its Neutral rating.<\/p>\n<p><strong>EPAM Systems (EPAM)<\/strong> \u2014 Guggenheim raises its price target to $160.00 from $140.00, maintaining a Buy rating.<\/p>\n<p><strong>EPR Properties (EPR)<\/strong> \u2014 Citigroup lowers its price target to $63.00 from $65.00, maintaining a Neutral rating.<\/p>\n<p><strong>EQT (EQT)<\/strong> \u2014 Truist raises its price target to $70.00 from $65.00, maintaining a Buy rating.<\/p>\n<p><strong>Equinix (EQIX)<\/strong> \u2014 BMO Capital Markets reiterates its Outperform rating with a $1,250.00 price target.<\/p>\n<p><strong>Everest Group (EG)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $419.00 from $390.00, maintaining a Neutral rating.<\/p>\n<p><strong>Everest Group (EG)<\/strong> \u2014 Citigroup raises its price target to $445.00 from $415.00, maintaining a Neutral rating.<\/p>\n<p><strong>Everest Group (EG)<\/strong> \u2014 UBS raises its price target to $423.00 from $395.00, maintaining a Neutral rating.<\/p>\n<p><strong>Everest Group (EG)<\/strong> \u2014 Wells Fargo raises its price target to $428.00 from $396.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Exelixis (EXEL)<\/strong> \u2014 HC Wainwright raises its price target to $78.00 from $56.00, maintaining a Buy rating.<\/p>\n<p><strong>ExxonMobil (XOM)<\/strong> \u2014 Morgan Stanley raises its price target to $187.00 from $185.00, maintaining an Overweight rating.<\/p>\n<p><strong>ExxonMobil (XOM)<\/strong> \u2014 UBS raises its price target to $213.00 from $199.00, maintaining a Buy rating.<\/p>\n<p><strong>ExxonMobil (XOM)<\/strong> \u2014 Wells Fargo raises its price target to $189.00 from $182.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Fair Isaac (FICO)<\/strong> \u2014 Jefferies lowers its price target to $925.00 from $1,675.00, maintaining a Buy rating.<\/p>\n<p><strong>Farmers National Banc (FMNB)<\/strong> \u2014 Raymond James downgrades the stock from Outperform to Market Perform.<\/p>\n<p><strong>Federal Realty Investment Trust (FRT)<\/strong> \u2014 Piper Sandler raises its price target to $135.00 from $131.00, maintaining an Overweight rating.<\/p>\n<p><strong>Federal Signal (FSS)<\/strong> \u2014 Citigroup lowers its price target to $135.00 from $150.00, maintaining a Buy rating.<\/p>\n<p><strong>Federal Signal (FSS)<\/strong> \u2014 DA Davidson lowers its price target to $126.00 from $132.00, maintaining a Neutral rating.<\/p>\n<p><strong>Federated Hermes (FHI)<\/strong> \u2014 JPMorgan raises its price target to $56.00 from $54.00, maintaining an Underweight rating.<\/p>\n<p><strong>Federated Hermes (FHI)<\/strong> \u2014 TD Cowen raises its price target to $62.00 from $56.00, maintaining a Hold rating.<\/p>\n<p><strong>FedEx (FDX)<\/strong> \u2014 Citigroup raises its price target to $374.00 from $373.00, maintaining a Buy rating.<\/p>\n<p><strong>Figma (FIG)<\/strong> \u2014 Rothschild &amp; Co Redburn initiates coverage with a Neutral rating with a $23.00 price target.<\/p>\n<p><strong>Financial Institutions (FISI)<\/strong> \u2014 Keefe, Bruyette &amp; Woods reiterates its Outperform rating.<\/p>\n<p><strong>Firefly Aerospace (FLY)<\/strong> \u2014 KeyCorp lowers its price target to $35.00 from $50.00, maintaining an Overweight rating.<\/p>\n<p><strong>First Business Financial Services (FBIZ)<\/strong> \u2014 DA Davidson raises its price target to $85.00 from $80.00, maintaining a Buy rating.<\/p>\n<p><strong>First Business Financial Services (FBIZ)<\/strong> \u2014 Piper Sandler raises its price target to $88.00 from $84.00, maintaining an Overweight rating.<\/p>\n<p><strong>First Business Financial Services (FBIZ)<\/strong> \u2014 Raymond James reiterates its Outperform rating with a $83.00 price target.<\/p>\n<p><strong>First Financial Bancorp. (FFBC)<\/strong> \u2014 Truist raises its price target to $38.00 from $37.00, maintaining a Buy rating.<\/p>\n<p><strong>First Industrial Realty Trust (FR)<\/strong> \u2014 Wells Fargo lowers its price target to $60.00 from $66.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>First Mid Bancshares (FMBH)<\/strong> \u2014 Piper Sandler raises its price target to $64.00 from $62.50, maintaining an Overweight rating.<\/p>\n<p><strong>First Northwest Bancorp (FNWB)<\/strong> \u2014 Piper Sandler lowers its price target to $14.00 from $15.00, maintaining an Overweight rating.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Barclays PLC lowers its price target to $230.00 from $259.00, maintaining an Overweight rating.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Guggenheim lowers its price target to $297.00 from $299.00, maintaining a Buy rating.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Mizuho sets a $328.00 price target.<\/p>\n<p><strong>First Solar (FSLR)<\/strong> \u2014 Robert W. Baird lowers its price target to $266.00 from $290.00, maintaining an Outperform rating.<\/p>\n<p><strong>Five Star Bancorp (FSBC)<\/strong> \u2014 Stephens lowers its price target to $49.00 from $50.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Fiverr International (FVRR)<\/strong> \u2014 Citigroup lowers its price target to $10.00 from $11.50, maintaining a Neutral rating.<\/p>\n<p><strong>Fiverr International (FVRR)<\/strong> \u2014 Goldman Sachs raises its price target to $10.00 from $9.00, maintaining a Neutral rating.<\/p>\n<p><strong>Floor &amp; Decor (FND)<\/strong> \u2014 Morgan Stanley lowers its price target to $60.00 from $64.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Floor &amp; Decor (FND)<\/strong> \u2014 Stifel Nicolaus lowers its price target to $51.00 from $52.00, maintaining a Hold rating.<\/p>\n<p><strong>Floor &amp; Decor (FND)<\/strong> \u2014 Goldman Sachs downgrades the stock from Neutral to Sell with a $38.00 price target.<\/p>\n<p><strong>Flowers Foods (FLO)<\/strong> \u2014 Stephens lowers its price target to $5.50 from $6.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Fluence Energy (FLNC)<\/strong> \u2014 BMO Capital Markets reiterates its Market Perform rating.<\/p>\n<p><strong>Flutter Entertainment (FLUT)<\/strong> \u2014 Oppenheimer Holdings, Inc. lowers its price target to $110.00 from $120.00, maintaining an Outperform rating.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 Jefferies initiates coverage with a Hold rating with a $6.00 price target.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 Morgan Stanley lowers its price target to $8.00 from $12.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>FMC (FMC)<\/strong> \u2014 RBC Capital lowers its price target to $7.00 from $9.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Fortrea (FTRE)<\/strong> \u2014 TD Cowen raises its price target to $26.00 from $23.00, maintaining a Buy rating.<\/p>\n<p><strong>Four Corners Property Trust (FCPT)<\/strong> \u2014 Citigroup reiterates its Market Outperform rating.<\/p>\n<p><strong>Four Corners Property Trust (FCPT)<\/strong> \u2014 Citizens Jmp lowers its price target to $26.00 from $28.00, maintaining a Market Outperform rating.<\/p>\n<p><strong>Four Corners Property Trust (FCPT)<\/strong> \u2014 RBC Capital sets a $26.00 price target.<\/p>\n<p><strong>Franklin BSP Realty Trust (FBRT)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $10.00 from $13.00, maintaining a Buy rating.<\/p>\n<p><strong>Franklin Electric (FELE)<\/strong> \u2014 DA Davidson upgrades the stock from Neutral to Buy with a $135.00 price target.<\/p>\n<p><strong>Freeport-McMoRan (FCX)<\/strong> \u2014 Freedom Broker lowers its price target to $68.00 from $75.00, maintaining a Hold rating.<\/p>\n<p><strong>FTI Consulting (FCN)<\/strong> \u2014 Truist reiterates its Hold rating with a $180.00 price target.<\/p>\n<p><strong>Full House Resorts (FLL)<\/strong> \u2014 Texas Capital downgrades the stock from Strong-Buy to Hold.<\/p>\n<p><strong>Garmin (GRMN)<\/strong> \u2014 BofA Securities reiterates its Underperform rating.<\/p>\n<p><strong>Gates Industrial (GTES)<\/strong> \u2014 DA Davidson lowers its price target to $27.00 from $29.00, maintaining a Neutral rating.<\/p>\n<p><strong>Gates Industrial (GTES)<\/strong> \u2014 Robert W. Baird raises its price target to $40.00 from $39.00, maintaining an Outperform rating.<\/p>\n<p><strong>Gates Industrial (GTES)<\/strong> \u2014 Wells Fargo lowers its price target to $28.00 from $30.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>GE Vernova (GEV)<\/strong> \u2014 Guggenheim lowers its price target to $1,400.00 from $1,450.00, maintaining a Buy rating.<\/p>\n<p><strong>General Dynamics (GD)<\/strong> \u2014 Citigroup raises its price target to $400.00 from $374.00, maintaining a Neutral rating.<\/p>\n<p><strong>General Dynamics (GD)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $455.00 price target.<\/p>\n<p><strong>General Dynamics (GD)<\/strong> \u2014 RBC Capital raises its price target to $400.00 from $360.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>GFL Environmental (GFL)<\/strong> \u2014 Citigroup raises its price target to $52.00 from $51.00, maintaining a Buy rating.<\/p>\n<p><strong>Gilead Sciences (GILD)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating with a $175.00 price target.<\/p>\n<p><strong>GlobalFoundries (GFS)<\/strong> \u2014 Morgan Stanley lowers its price target to $56.00 from $60.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>GoDaddy (GDDY)<\/strong> \u2014 Citigroup raises its price target to $135.00 from $105.00, maintaining a Buy rating.<\/p>\n<p><strong>Granite Construction (GVA)<\/strong> \u2014 Goldman Sachs raises its price target to $124.00 from $110.00, maintaining a Sell rating.<\/p>\n<p><strong>H2O America (HTO)<\/strong> \u2014 Mizuho initiates coverage with an Outperform rating with a $67.00 price target.<\/p>\n<p><strong>Hamilton Insurance Group (HG)<\/strong> \u2014 Wells Fargo raises its price target to $43.00 from $40.00, maintaining an Overweight rating.<\/p>\n<p><strong>HCA Healthcare (HCA)<\/strong> \u2014 Wells Fargo raises its price target to $468.00 from $381.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Hershey (HSY)<\/strong> \u2014 Barclays PLC lowers its price target to $171.00 from $178.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>HF Sinclair (DINO)<\/strong> \u2014 Morgan Stanley raises its price target to $130.00 from $127.00, maintaining an Overweight rating.<\/p>\n<p><strong>Hilton Grand Vacations (HGV)<\/strong> \u2014 Barclays PLC lowers its price target to $39.00 from $46.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Hilton Grand Vacations (HGV)<\/strong> \u2014 Citigroup downgrades the stock from Market Outperform to Market Perform.<\/p>\n<p><strong>Hilton Grand Vacations (HGV)<\/strong> \u2014 Citizens Jmp downgrades the stock from Market Outperform to Market Perform.<\/p>\n<p><strong>Honeywell Aerospace (HONA)<\/strong> \u2014 Jefferies reiterates its Hold rating with a $170.00 price target.<\/p>\n<p><strong>Hope Bancorp (HOPE)<\/strong> \u2014 Piper Sandler lowers its price target to $13.00 from $15.00, maintaining a Neutral rating.<\/p>\n<p><strong>Howmet Aerospace (HWM)<\/strong> \u2014 BTIG Research lowers its price target to $280.00 from $340.00, maintaining a Buy rating.<\/p>\n<p><strong>Howmet Aerospace (HWM)<\/strong> \u2014 Jefferies lowers its price target to $350.00 from $370.00, maintaining a Buy rating.<\/p>\n<p><strong>Hyatt Hotels (H)<\/strong> \u2014 Freedom Broker raises its price target to $206.00 from $192.00, maintaining a Buy rating.<\/p>\n<p><strong>Hyatt Hotels (H)<\/strong> \u2014 Robert W. Baird raises its price target to $194.00 from $188.00, maintaining a Neutral rating.<\/p>\n<p><strong>IDACORP (IDA)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a $155.00 price target.<\/p>\n<p><strong>Illumina (ILMN)<\/strong> \u2014 Citigroup raises its price target to $210.00 from $113.00, maintaining a Sell rating.<\/p>\n<p><strong>Impinj (PI)<\/strong> \u2014 Barclays PLC raises its price target to $217.00 from $200.00, maintaining an Overweight rating.<\/p>\n<p><strong>Incyte (INCY)<\/strong> \u2014 Sanford C. Bernstein raises its price target to $108.00 from $104.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Industrial Logistics Properties Trust (ILPT)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $10.00 from $11.00, maintaining a Buy rating.<\/p>\n<p><strong>Infleqtion (INFQ)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $17.00 from $23.00, maintaining a Buy rating.<\/p>\n<p><strong>Ingersoll Rand (IR)<\/strong> \u2014 Robert W. Baird lowers its price target to $107.00 from $109.00, maintaining an Outperform rating.<\/p>\n<p><strong>Ingersoll Rand (IR)<\/strong> \u2014 Stifel Nicolaus reiterates its Buy rating with a $95.00 price target.<\/p>\n<p><strong>Inovio Pharmaceuticals (INO)<\/strong> \u2014 HC Wainwright sets a $5.00 price target, with a Neutral ? Buy rating.<\/p>\n<p><strong>Inovio Pharmaceuticals (INO)<\/strong> \u2014 HC Wainwright upgrades the stock from Neutral to Buy.<\/p>\n<p><strong>Insmed (INSM)<\/strong> \u2014 Benchmark Co. reiterates its Buy rating.<\/p>\n<p><strong>Insmed (INSM)<\/strong> \u2014 Guggenheim lowers its price target to $201.00 from $205.00, maintaining a Buy rating.<\/p>\n<p><strong>Intrepid Potash (IPI)<\/strong> \u2014 Freedom Broker lowers its price target to $41.00 from $44.00, maintaining a Buy rating.<\/p>\n<p><strong>Intrepid Potash (IPI)<\/strong> \u2014 UBS reiterates its Buy rating.<\/p>\n<p><strong>Intuitive Machines (LUNR)<\/strong> \u2014 KeyCorp lowers its price target to $30.00 from $38.00, maintaining an Overweight rating.<\/p>\n<p><strong>IonQ (IONQ)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $75.00 from $100.00, maintaining a Buy rating.<\/p>\n<p><strong>Janus Living (JAN)<\/strong> \u2014 Mizuho initiates coverage with an Outperform rating with a $33.00 price target.<\/p>\n<p><strong>JinkoSolar (JKS)<\/strong> \u2014 Roth Capital lowers its price target to $10.00 from $16.00, maintaining a Neutral rating.<\/p>\n<p><strong>JPMorgan Chase &amp; Co. (JPM)<\/strong> \u2014 UBS raises its price target to $400.00 from $395.00, maintaining a Buy rating.<\/p>\n<p><strong>Karman (KRMN)<\/strong> \u2014 KeyCorp lowers its price target to $65.00 from $100.00, maintaining an Overweight rating.<\/p>\n<p><strong>KBR (KBR)<\/strong> \u2014 Wells Fargo raises its price target to $40.00 from $35.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Kenvue (KVUE)<\/strong> \u2014 UBS raises its price target to $20.00 from $19.00, maintaining a Neutral rating.<\/p>\n<p><strong>Kilroy Realty (KRC)<\/strong> \u2014 Wells Fargo lowers its price target to $36.00 from $38.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Kimco Realty (KIM)<\/strong> \u2014 Piper Sandler raises its price target to $30.00 from $27.00, maintaining an Overweight rating.<\/p>\n<p><strong>Kinder Morgan (KMI)<\/strong> \u2014 JPMorgan raises its price target to $37.00 from $36.00, maintaining a Neutral rating.<\/p>\n<p><strong>Kratos Defense &amp; Security Solutions (KTOS)<\/strong> \u2014 KeyCorp lowers its price target to $75.00 from $130.00, maintaining an Overweight rating.<\/p>\n<p><strong>Kymera Therapeutics (KYMR)<\/strong> \u2014 Barclays PLC raises its price target to $170.00 from $139.00, maintaining an Overweight rating.<\/p>\n<p><strong>Landstar System (LSTR)<\/strong> \u2014 Susquehanna lowers its price target to $160.00 from $190.00, maintaining a Neutral rating.<\/p>\n<p><strong>Lear (LEA)<\/strong> \u2014 RBC Capital lowers its price target to $135.00 from $139.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Lennar (LEN)<\/strong> \u2014 Wells Fargo raises its price target to $80.00 from $75.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Leonardo DRS (DRS)<\/strong> \u2014 BTIG Research reiterates its Buy rating with a $50.00 price target.<\/p>\n<p><strong>Leonardo DRS (DRS)<\/strong> \u2014 Morgan Stanley raises its price target to $45.00 from $44.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Lockheed Martin (LMT)<\/strong> \u2014 Wells Fargo raises its price target to $700.00 from $600.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Lumentum (LITE)<\/strong> \u2014 Mizuho sets a $1,132.00 price target.<\/p>\n<p><strong>Lumentum (LITE)<\/strong> \u2014 Raymond James upgrades the stock from Outperform to Strong-Buy with a $1,328.00 price target.<\/p>\n<p><strong>Lumentum (LITE)<\/strong> \u2014 Stifel Nicolaus sets a $806.00 price target.<\/p>\n<p><strong>Lyft (LYFT)<\/strong> \u2014 UBS raises its price target to $18.00 from $17.00, maintaining a Neutral rating.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 BofA Securities reiterates its Underperform rating with a $66.00 price target.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 Barclays PLC raises its price target to $69.00 from $66.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 BMO Capital Markets reiterates its Outperform rating with a $72.00 price target.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 Mizuho sets a $68.00 price target.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 RBC Capital raises its price target to $82.00 from $68.00, maintaining an Outperform rating.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 Goldman Sachs reiterates its Sell rating with a $69.00 price target.<\/p>\n<p><strong>LyondellBasell Industries (LYB)<\/strong> \u2014 Wells Fargo raises its price target to $76.00 from $70.00, maintaining an Overweight rating.<\/p>\n<p><strong>Magna International (MGA)<\/strong> \u2014 RBC Capital lowers its price target to $66.00 from $68.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Manhattan Associates (MANH)<\/strong> \u2014 Barclays PLC raises its price target to $275.00 from $239.00, maintaining an Overweight rating.<\/p>\n<p><strong>Maplebear (CART)<\/strong> \u2014 Citigroup raises its price target to $65.00 from $58.00, maintaining a Buy rating.<\/p>\n<p><strong>Marriott International (MAR)<\/strong> \u2014 Stifel Nicolaus sets a $402.00 price target.<\/p>\n<p><strong>Marvell Technology (MRVL)<\/strong> \u2014 William Blair reiterates its Outperform rating.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 Cantor Fitzgerald lowers its price target to $270.00 from $348.00, maintaining an Overweight rating.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 Roth Capital reiterates its Buy rating with a $380.00 price target.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 TD Cowen lowers its price target to $310.00 from $320.00, maintaining a Buy rating.<\/p>\n<p><strong>MasTec (MTZ)<\/strong> \u2014 Truist reiterates its Buy rating with a $332.00 price target.<\/p>\n<p><strong>Merck &amp; Co., Inc. (MRK)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $155.00 from $145.00, maintaining a Neutral rating.<\/p>\n<p><strong>Merck &amp; Co., Inc. (MRK)<\/strong> \u2014 Freedom Broker raises its price target to $140.00 from $125.00, maintaining a Hold rating.<\/p>\n<p><strong>Methanex (MEOH)<\/strong> \u2014 Canadian Imperial Bank of Commerce raises its price target to $83.00 from $77.00, maintaining an Outperformer rating.<\/p>\n<p><strong>Methanex (MEOH)<\/strong> \u2014 JPMorgan raises its price target to $63.00 from $55.00, maintaining a Neutral rating.<\/p>\n<p><strong>Methanex (MEOH)<\/strong> \u2014 Raymond James sets a $80.00 price target.<\/p>\n<p><strong>Methanex (MEOH)<\/strong> \u2014 RBC Capital raises its price target to $75.00 from $65.00, maintaining a Sector Perform ? Outperform rating.<\/p>\n<p><strong>Mid-America Apartment Communities (MAA)<\/strong> \u2014 Piper Sandler raises its price target to $125.00 from $121.00, maintaining a Neutral rating.<\/p>\n<p><strong>MidCap Financial Investment (MFIC)<\/strong> \u2014 Truist downgrades the stock from Buy to Hold with a $11.00 price target.<\/p>\n<p><strong>Middlesex Water (MSEX)<\/strong> \u2014 Freedom Broker raises its price target to $58.00 from $56.00, maintaining a Hold rating.<\/p>\n<p><strong>Mobileye Global (MBLY)<\/strong> \u2014 Barclays PLC lowers its price target to $7.00 from $9.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Mobileye Global (MBLY)<\/strong> \u2014 BNP Paribas Exane lowers its price target to $6.50 from $7.50, maintaining a Neutral rating.<\/p>\n<p><strong>Mobileye Global (MBLY)<\/strong> \u2014 JPMorgan lowers its price target to $7.50 from $9.00, maintaining a Neutral rating.<\/p>\n<p><strong>Mohawk Industries (MHK)<\/strong> \u2014 BofA Securities reiterates its Neutral rating.<\/p>\n<p><strong>Mohawk Industries (MHK)<\/strong> \u2014 Barclays PLC raises its price target to $125.00 from $115.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Mohawk Industries (MHK)<\/strong> \u2014 Evercore Inc upgrades the stock from In-Line to Outperform with a $171.00 price target.<\/p>\n<p><strong>Mohawk Industries (MHK)<\/strong> \u2014 Robert W. Baird raises its price target to $142.00 from $132.00, maintaining a Neutral rating.<\/p>\n<p><strong>Molecular Partners (MOLN)<\/strong> \u2014 HC Wainwright reiterates its Buy rating.<\/p>\n<p><strong>Mondelez International (MDLZ)<\/strong> \u2014 UBS reiterates its Neutral rating with a $72.00 price target.<\/p>\n<p><strong>Morgan Stanley (MS)<\/strong> \u2014 UBS raises its price target to $240.00 from $236.00, maintaining a Buy rating.<\/p>\n<p><strong>Mosaic (MOS)<\/strong> \u2014 Freedom Broker upgrades the stock from Sell to Hold with a $17.00 price target.<\/p>\n<p><strong>MSCI (MSCI)<\/strong> \u2014 Barclays PLC raises its price target to $760.00 from $735.00, maintaining an Overweight rating.<\/p>\n<p><strong>Nano Nuclear Energy (NNE)<\/strong> \u2014 Wedbush initiates coverage with an Outperform rating with a $18.00 price target.<\/p>\n<p><strong>NAPCO Security Technologies (NSSC)<\/strong> \u2014 Needham &amp; Company LLC lowers its price target to $43.00 from $49.00, maintaining a Buy rating.<\/p>\n<p><strong>National Bank (NBHC)<\/strong> \u2014 Stephens lowers its price target to $39.00 from $44.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>National CineMedia (NCMI)<\/strong> \u2014 National Bank Financial sets a $1.75 price target.<\/p>\n<p><strong>NBT Bancorp (NBTB)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a $61.00 price target.<\/p>\n<p><strong>Netskope (NTSK)<\/strong> \u2014 BTIG Research raises its price target to $30.00 from $22.00, maintaining a Buy rating.<\/p>\n<p><strong>Newell Brands (NWL)<\/strong> \u2014 Citigroup lowers its price target to $5.50 from $6.00, maintaining a Neutral rating.<\/p>\n<p><strong>Newell Brands (NWL)<\/strong> \u2014 UBS raises its price target to $5.75 from $5.50, maintaining a Neutral rating.<\/p>\n<p><strong>Nkarta (NKTX)<\/strong> \u2014 HC Wainwright initiates coverage with a Buy rating.<\/p>\n<p><strong>NPK International (NPKI)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $15.00 from $21.00, maintaining a Buy rating.<\/p>\n<p><strong>Nucor (NUE)<\/strong> \u2014 Wedbush sets a $304.00 price target.<\/p>\n<p><strong>nVent Electric (NVT)<\/strong> \u2014 Citigroup lowers its price target to $200.00 from $228.00, maintaining a Buy rating.<\/p>\n<p><strong>nVent Electric (NVT)<\/strong> \u2014 KeyCorp reiterates its Overweight rating.<\/p>\n<p><strong>nVent Electric (NVT)<\/strong> \u2014 Sanford C. Bernstein reiterates its Outperform rating with a $233.00 price target.<\/p>\n<p><strong>nVent Electric (NVT)<\/strong> \u2014 Wells Fargo raises its price target to $190.00 from $182.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>NVIDIA (NVDA)<\/strong> \u2014 Melius Research lowers its price target to $315.00 from $420.00, maintaining a Buy rating.<\/p>\n<p><strong>Oil States International (OIS)<\/strong> \u2014 Susquehanna raises its price target to $10.00 from $9.00, maintaining a Neutral rating.<\/p>\n<p><strong>Olin (OLN)<\/strong> \u2014 Citigroup raises its price target to $19.00 from $17.00, maintaining a Neutral rating.<\/p>\n<p><strong>Olin (OLN)<\/strong> \u2014 RBC Capital raises its price target to $19.00 from $16.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Olin (OLN)<\/strong> \u2014 Truist raises its price target to $17.00 from $15.00, maintaining a Hold rating.<\/p>\n<p><strong>Ondas (ONDS)<\/strong> \u2014 Goldman Sachs upgrades the stock to Buy.<\/p>\n<p><strong>OneMain (OMF)<\/strong> \u2014 BofA Securities lowers its price target to $66.00 from $67.00, maintaining a Buy rating.<\/p>\n<p><strong>OneMain (OMF)<\/strong> \u2014 Barclays PLC lowers its price target to $59.00 from $60.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>OneMain (OMF)<\/strong> \u2014 JPMorgan raises its price target to $56.00 from $52.00, maintaining an Underweight rating.<\/p>\n<p><strong>OneMain (OMF)<\/strong> \u2014 RBC Capital lowers its price target to $70.00 from $71.00, maintaining an Outperform rating.<\/p>\n<p><strong>ONEOK (OKE)<\/strong> \u2014 Freedom Broker raises its price target to $110.00 from $105.00, maintaining a Buy rating.<\/p>\n<p><strong>Oracle (ORCL)<\/strong> \u2014 BTIG Research initiates coverage with a Buy rating.<\/p>\n<p><strong>Oracle (ORCL)<\/strong> \u2014 HC Wainwright initiates coverage with a Buy rating.<\/p>\n<p><strong>Oracle (ORCL)<\/strong> \u2014 Morgan Stanley downgrades the stock from Positive to Underweight.<\/p>\n<p><strong>Oracle (ORCL)<\/strong> \u2014 Stephens upgrades the stock from Equal Weight to Overweight with a $213.00 price target.<\/p>\n<p><strong>Oracle (ORCL)<\/strong> \u2014 Goldman Sachs downgrades the stock from Neutral to Sell.<\/p>\n<p><strong>Oshkosh (OSK)<\/strong> \u2014 Citigroup raises its price target to $140.00 from $135.00, maintaining a Neutral rating.<\/p>\n<p><strong>Oshkosh (OSK)<\/strong> \u2014 DA Davidson lowers its price target to $164.00 from $168.00, maintaining a Buy rating.<\/p>\n<p><strong>Palantir Technologies (PLTR)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $207.00 from $156.00, maintaining a Neutral rating.<\/p>\n<p><strong>Pampa Energia (PAM)<\/strong> \u2014 JPMorgan lowers its price target to $100.00 from $105.00, maintaining a Neutral rating.<\/p>\n<p><strong>Papa John&#8217;s International (PZZA)<\/strong> \u2014 UBS lowers its price target to $21.00 from $28.00, maintaining a Neutral rating.<\/p>\n<p><strong>Park Aerospace (PKE)<\/strong> \u2014 Goldman Sachs upgrades the stock to Buy.<\/p>\n<p><strong>Pattern Group (PTRN)<\/strong> \u2014 KeyCorp lowers its price target to $25.00 from $30.00, maintaining an Overweight rating.<\/p>\n<p><strong>Patterson-UTI Energy (PTEN)<\/strong> \u2014 Morgan Stanley raises its price target to $13.00 from $12.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>PBF Energy (PBF)<\/strong> \u2014 Freedom Broker upgrades the stock from Sell to Hold with a $63.00 price target.<\/p>\n<p><strong>PBF Energy (PBF)<\/strong> \u2014 Piper Sandler raises its price target to $97.00 from $94.00, maintaining a Neutral rating.<\/p>\n<p><strong>PennyMac Financial Services (PFSI)<\/strong> \u2014 Barclays PLC lowers its price target to $67.00 from $71.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>PennyMac Financial Services (PFSI)<\/strong> \u2014 Keefe, Bruyette &amp; Woods downgrades the stock from Moderate Buy to Hold with a $80.00 price target.<\/p>\n<p><strong>Perion Network (PERI)<\/strong> \u2014 Craig Hallum downgrades the stock from Buy to Hold with a $11.70 price target.<\/p>\n<p><strong>Permian Resources (PR)<\/strong> \u2014 Raymond James reiterates its Strong-Buy rating with a $34.00 price target.<\/p>\n<p><strong>Phillips 66 (PSX)<\/strong> \u2014 Morgan Stanley raises its price target to $290.00 from $284.00, maintaining an Overweight rating.<\/p>\n<p><strong>Pinterest (PINS)<\/strong> \u2014 Citigroup lowers its price target to $22.00 from $27.00, maintaining a Neutral rating.<\/p>\n<p><strong>Pinterest (PINS)<\/strong> \u2014 DA Davidson lowers its price target to $25.00 from $27.00, maintaining a Buy rating.<\/p>\n<p><strong>Pinterest (PINS)<\/strong> \u2014 KeyCorp lowers its price target to $25.00 from $28.00, maintaining an Overweight rating.<\/p>\n<p><strong>Plexus (PLXS)<\/strong> \u2014 Fox Advisors upgrades the stock from Equal Weight to Overweight.<\/p>\n<p><strong>Procore Technologies (PCOR)<\/strong> \u2014 TD Cowen raises its price target to $70.00 from $65.00, maintaining a Buy rating.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $149.00 price target.<\/p>\n<p><strong>Prologis (PLD)<\/strong> \u2014 Wells Fargo lowers its price target to $158.00 from $166.00, maintaining an Overweight rating.<\/p>\n<p><strong>Promis Neurosciences (PMN)<\/strong> \u2014 Roth Capital lowers its price target to $15.00, maintaining a Buy rating.<\/p>\n<p><strong>Proto Labs (PRLB)<\/strong> \u2014 William Blair reiterates its Market Perform rating.<\/p>\n<p><strong>PTC Therapeutics (PTCT)<\/strong> \u2014 Citigroup raises its price target to $109.00 from $108.00, maintaining a Buy rating.<\/p>\n<p><strong>Quaker Houghton (KWR)<\/strong> \u2014 RBC Capital lowers its price target to $192.00 from $202.00, maintaining an Outperform rating.<\/p>\n<p><strong>Quaker Houghton (KWR)<\/strong> \u2014 Truist raises its price target to $192.00 from $190.00, maintaining a Buy rating.<\/p>\n<p><strong>Qualcomm (QCOM)<\/strong> \u2014 Sanford C. Bernstein lowers its price target to $155.00 from $165.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Quanta Services (PWR)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $760.00 price target.<\/p>\n<p><strong>Quanta Services (PWR)<\/strong> \u2014 Oppenheimer Holdings, Inc. lowers its price target to $800.00 from $835.00, maintaining an Outperform rating.<\/p>\n<p><strong>Range Resources (RRC)<\/strong> \u2014 Truist raises its price target to $51.00 from $43.00, maintaining a Hold rating.<\/p>\n<p><strong>RBC Bearings (RBC)<\/strong> \u2014 Morgan Stanley lowers its price target to $600.00 from $655.00, maintaining an Overweight rating.<\/p>\n<p><strong>RBC Bearings (RBC)<\/strong> \u2014 Goldman Sachs reiterates its Neutral rating with a $530.00 price target.<\/p>\n<p><strong>Red River Bancshares (RRBI)<\/strong> \u2014 Stephens reiterates its Equal Weight rating with a $115.00 price target.<\/p>\n<p><strong>Reddit (RDDT)<\/strong> \u2014 DA Davidson lowers its price target to $125.00 from $185.00, maintaining a Buy rating.<\/p>\n<p><strong>Reddit (RDDT)<\/strong> \u2014 Evercore Inc downgrades the stock from Outperform to Hold with a $120.00 price target.<\/p>\n<p><strong>Reddit (RDDT)<\/strong> \u2014 Loop Capital downgrades the stock from Buy to Hold with a $100.00 price target.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 BofA Securities raises its price target to $1,030.00 from $908.00, maintaining a Buy rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Cantor Fitzgerald raises its price target to $980.00 from $795.00, maintaining an Overweight rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Guggenheim raises its price target to $1,100.00 from $1,030.00, maintaining a Buy rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Leerink Partners raises its price target to $997.00 from $835.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Morgan Stanley raises its price target to $855.00 from $779.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Robert W. Baird raises its price target to $875.00 from $761.00, maintaining a Neutral rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 RBC Capital raises its price target to $913.00 from $810.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Sanford C. Bernstein raises its price target to $812.00 from $756.00, maintaining a Market Perform rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Truist raises its price target to $982.00 from $780.00, maintaining a Buy rating.<\/p>\n<p><strong>Regeneron Pharmaceuticals (REGN)<\/strong> \u2014 Wells Fargo raises its price target to $925.00 from $750.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>RenaissanceRe (RNR)<\/strong> \u2014 Mizuho sets a $352.00 price target.<\/p>\n<p><strong>RenaissanceRe (RNR)<\/strong> \u2014 UBS raises its price target to $366.00 from $349.00, maintaining a Neutral rating.<\/p>\n<p><strong>RenaissanceRe (RNR)<\/strong> \u2014 Wells Fargo raises its price target to $338.00 from $319.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Republic Services (RSG)<\/strong> \u2014 Barclays PLC raises its price target to $254.00 from $240.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Republic Services (RSG)<\/strong> \u2014 Citigroup raises its price target to $281.00 from $259.00, maintaining a Buy rating.<\/p>\n<p><strong>Republic Services (RSG)<\/strong> \u2014 Wells Fargo raises its price target to $270.00 from $234.00, maintaining an Overweight rating.<\/p>\n<p><strong>ResMed (RMD)<\/strong> \u2014 Canaccord Genuity downgrades the stock from Buy to Hold.<\/p>\n<p><strong>Retension Pharmaceuticals (RTSN)<\/strong> \u2014 Guggenheim initiates coverage with a Buy rating with a $55.00 price target.<\/p>\n<p><strong>Rexford Industrial Realty (REXR)<\/strong> \u2014 Wells Fargo raises its price target to $47.00 from $43.00, maintaining an Overweight rating.<\/p>\n<p><strong>Rigetti Computing (RGTI)<\/strong> \u2014 B. Riley Financial, Inc. lowers its price target to $25.00 from $35.00, maintaining a Buy rating.<\/p>\n<p><strong>Rivian Automotive (RIVN)<\/strong> \u2014 UBS upgrades the stock from Neutral to Buy with a $17.00 price target.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 B. Riley Financial, Inc. raises its price target to $51.00 from $45.00, maintaining a Buy rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 Citigroup lowers its price target to $55.00 from $60.00, maintaining a Buy rating.<\/p>\n<p><strong>Roblox (RBLX)<\/strong> \u2014 DA Davidson lowers its price target to $48.00 from $50.00, maintaining a Neutral rating.<\/p>\n<p><strong>Rush Street Interactive (RSI)<\/strong> \u2014 Craig Hallum downgrades the stock from Buy to Hold with a $15.00 price target.<\/p>\n<p><strong>RXO (RXO)<\/strong> \u2014 Susquehanna raises its price target to $30.00 from $19.00, maintaining a Neutral rating.<\/p>\n<p><strong>Ryan Specialty (RYAN)<\/strong> \u2014 UBS lowers its price target to $52.00 from $55.00, maintaining a Buy rating.<\/p>\n<p><strong>Ryan Specialty (RYAN)<\/strong> \u2014 Wells Fargo raises its price target to $46.00 from $41.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>S&amp;P Global (SPGI)<\/strong> \u2014 Barclays PLC raises its price target to $572.00 from $553.00, maintaining an Overweight rating.<\/p>\n<p><strong>Sandisk (SNDK)<\/strong> \u2014 Fox Advisors downgrades the stock from Overweight to Equal Weight.<\/p>\n<p><strong>Scorpio Tankers (STNG)<\/strong> \u2014 Evercore Inc sets a $105.00 price target.<\/p>\n<p><strong>Scotts Miracle-Gro (SMG)<\/strong> \u2014 Citigroup reiterates its Overweight rating.<\/p>\n<p><strong>Scotts Miracle-Gro (SMG)<\/strong> \u2014 Wells Fargo raises its price target to $71.00 from $60.00, maintaining an Overweight rating.<\/p>\n<p><strong>Seagate Technology (STX)<\/strong> \u2014 UBS reiterates its Buy rating.<\/p>\n<p><strong>Sensient Technologies (SXT)<\/strong> \u2014 UBS lowers its price target to $154.00 from $157.00, maintaining a Buy rating.<\/p>\n<p><strong>SharkNinja (SN)<\/strong> \u2014 BTIG Research initiates coverage with a Buy rating with a $245.00 price target.<\/p>\n<p><strong>Shopify (SHOP)<\/strong> \u2014 KeyCorp raises its price target to $185.00 from $180.00, maintaining an Overweight rating.<\/p>\n<p><strong>Silgan (SLGN)<\/strong> \u2014 Citigroup raises its price target to $50.00 from $49.00, maintaining a Buy rating.<\/p>\n<p><strong>Silvaco Group (SVCO)<\/strong> \u2014 B. Riley Financial, Inc. reiterates its Buy rating with a $11.00 price target.<\/p>\n<p><strong>Skyworks Solutions (SWKS)<\/strong> \u2014 Morgan Stanley raises its price target to $95.00 from $72.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>SL Green Realty (SLG)<\/strong> \u2014 Wells Fargo lowers its price target to $54.00 from $56.50, maintaining an Equal Weight rating.<\/p>\n<p><strong>Smurfit Westrock (SW)<\/strong> \u2014 Citigroup lowers its price target to $50.00 from $54.00, maintaining a Buy rating.<\/p>\n<p><strong>Sonic Automotive (SAH)<\/strong> \u2014 Citigroup lowers its price target to $98.00 from $115.00, maintaining a Buy rating.<\/p>\n<p><strong>Sprouts Farmers Market (SFM)<\/strong> \u2014 Jefferies lowers its price target to $63.00 from $95.00, maintaining a Buy rating.<\/p>\n<p><strong>SPX Technologies (SPXC)<\/strong> \u2014 Oppenheimer Holdings, Inc. lowers its price target to $260.00 from $265.00, maintaining an Outperform rating.<\/p>\n<p><strong>SPX Technologies (SPXC)<\/strong> \u2014 Truist reiterates its Buy rating with a $233.00 price target.<\/p>\n<p><strong>Stag Industrial (STAG)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $43.00 price target.<\/p>\n<p><strong>Standard Motor Products (SMP)<\/strong> \u2014 Roth Capital reiterates its Buy rating with a $54.00 price target.<\/p>\n<p><strong>Starbucks (SBUX)<\/strong> \u2014 BofA Securities reiterates its Buy rating.<\/p>\n<p><strong>Starbucks (SBUX)<\/strong> \u2014 Citigroup raises its price target to $107.00 from $104.00, maintaining a Neutral rating.<\/p>\n<p><strong>Starbucks (SBUX)<\/strong> \u2014 Guggenheim reiterates its Neutral rating with a $103.00 price target.<\/p>\n<p><strong>Stryker (SYK)<\/strong> \u2014 Stifel Nicolaus lowers its price target to $325.00 from $330.00, maintaining a Buy rating.<\/p>\n<p><strong>Stryker (SYK)<\/strong> \u2014 Truist reiterates its Hold rating with a $305.00 price target.<\/p>\n<p><strong>SunCoke Energy (SXC)<\/strong> \u2014 B. Riley Financial, Inc. raises its price target to $11.00 from $9.00, maintaining a Neutral rating.<\/p>\n<p><strong>Synchrony Financial (SYF)<\/strong> \u2014 UBS lowers its price target to $80.00 from $81.00, maintaining a Neutral rating.<\/p>\n<p><strong>Take-Two Interactive Software (TTWO)<\/strong> \u2014 Piper Sandler reiterates its Overweight rating with a $290.00 price target.<\/p>\n<p><strong>Take-Two Interactive Software (TTWO)<\/strong> \u2014 Wedbush reiterates its Outperform rating with a $280.00 price target.<\/p>\n<p><strong>TE Connectivity (TEL)<\/strong> \u2014 Barclays PLC raises its price target to $304.00 from $300.00, maintaining an Overweight rating.<\/p>\n<p><strong>TE Connectivity (TEL)<\/strong> \u2014 Fox Advisors downgrades the stock from Overweight to Equal Weight.<\/p>\n<p><strong>TechnipFMC (FTI)<\/strong> \u2014 Barclays PLC raises its price target to $90.00 from $86.00, maintaining an Overweight rating.<\/p>\n<p><strong>Teladoc Health (TDOC)<\/strong> \u2014 Argus downgrades the stock from Hold to Sell.<\/p>\n<p><strong>Teladoc Health (TDOC)<\/strong> \u2014 Oppenheimer Holdings, Inc. raises its price target to $10.00 from $7.00, maintaining an Outperform rating.<\/p>\n<p><strong>Teladoc Health (TDOC)<\/strong> \u2014 UBS raises its price target to $9.00 from $6.50, maintaining a Neutral rating.<\/p>\n<p><strong>Tempus AI (TEM)<\/strong> \u2014 Needham &amp; Company LLC raises its price target to $89.00 from $75.00, maintaining a Buy rating.<\/p>\n<p><strong>Tenet Healthcare (THC)<\/strong> \u2014 Leerink Partners raises its price target to $342.00 from $309.00, maintaining an Outperform rating.<\/p>\n<p><strong>Tenet Healthcare (THC)<\/strong> \u2014 Mizuho sets a $305.00 price target.<\/p>\n<p><strong>Tenet Healthcare (THC)<\/strong> \u2014 RBC Capital raises its price target to $304.00 from $283.00, maintaining an Outperform rating.<\/p>\n<p><strong>Tenet Healthcare (THC)<\/strong> \u2014 Wells Fargo raises its price target to $321.00 from $281.00, maintaining an Overweight rating.<\/p>\n<p><strong>Terreno Realty (TRNO)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $74.00 price target.<\/p>\n<p><strong>Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 HC Wainwright initiates coverage with a Buy rating with a $52.00 price target.<\/p>\n<p><strong>Textron (TXT)<\/strong> \u2014 Citigroup raises its price target to $97.00 from $86.00, maintaining a Neutral rating.<\/p>\n<p><strong>Textron (TXT)<\/strong> \u2014 Freedom Broker lowers its price target to $101.00 from $108.00, maintaining a Buy rating.<\/p>\n<p><strong>Textron (TXT)<\/strong> \u2014 Morgan Stanley raises its price target to $95.00 from $86.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Canadian Imperial Bank of Commerce lowers its price target to $120.00 from $158.00, maintaining an Outperformer rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Citigroup lowers its price target to $123.00 from $157.00, maintaining a Buy rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Desjardins sets a $170.00 price target, with a Buy rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Morgan Stanley lowers its price target to $175.00 from $190.00, maintaining an Overweight rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 RBC Dominion Securities lowers its price target to $117.00 from $144.00, maintaining an Outperform rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 RBC Capital lowers its price target to $117.00 from $144.00, maintaining an Outperform rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Scotia lowers its price target to $138.00 from $168.00, maintaining a Sector Outperform rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Stephens lowers its price target to $140.00 from $160.00, maintaining an Overweight rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Stifel Nicolaus lowers its price target to $107.00 from $132.00, maintaining a Hold rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 TD Cowen lowers its price target to $119.00 from $158.00, maintaining a Buy rating.<\/p>\n<p><strong>TFI International (TFII)<\/strong> \u2014 Goldman Sachs lowers its price target to $155.00 from $178.00, maintaining a Buy rating.<\/p>\n<p><strong>TFS Financial (TFSL)<\/strong> \u2014 Piper Sandler lowers its price target to $18.00 from $18.50, maintaining a Neutral rating.<\/p>\n<p><strong>The Goldman Sachs Group (GS)<\/strong> \u2014 UBS lowers its price target to $1,000.00 from $1,010.00, maintaining a Neutral rating.<\/p>\n<p><strong>The Hartford Insurance Group (HIG)<\/strong> \u2014 Cantor Fitzgerald lowers its price target to $136.00 from $145.00, maintaining an Overweight rating.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 Oppenheimer Holdings, Inc. raises its price target to $274.00 from $269.00, maintaining an Outperform rating.<\/p>\n<p><strong>The PNC Financial Services Group (PNC)<\/strong> \u2014 UBS lowers its price target to $278.00 from $286.00, maintaining a Buy rating.<\/p>\n<p><strong>TIM (TIMB)<\/strong> \u2014 Barclays PLC lowers its price target to $22.00 from $24.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Titan International (TWI)<\/strong> \u2014 DA Davidson lowers its price target to $10.00 from $13.00, maintaining a Buy rating.<\/p>\n<p><strong>Trane Technologies (TT)<\/strong> \u2014 Citigroup lowers its price target to $549.00 from $566.00, maintaining a Buy rating.<\/p>\n<p><strong>Trulieve Cannabis (TRLV)<\/strong> \u2014 Cantor Fitzgerald reiterates its Overweight rating with a $15.00 price target.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 Oppenheimer Holdings, Inc. raises its price target to $74.00 from $73.00, maintaining an Outperform rating.<\/p>\n<p><strong>U.S. Bancorp (USB)<\/strong> \u2014 UBS raises its price target to $66.00 from $64.00, maintaining a Neutral rating.<\/p>\n<p><strong>Uber Technologies (UBER)<\/strong> \u2014 UBS lowers its price target to $106.00 from $110.00, maintaining a Buy rating.<\/p>\n<p><strong>United Rentals (URI)<\/strong> \u2014 Raymond James reiterates its Outperform rating with a $1,350.00 price target.<\/p>\n<p><strong>United States Lime &amp; Minerals (USLM)<\/strong> \u2014 Freedom Broker lowers its price target to $131.00 from $132.00, maintaining a Buy rating.<\/p>\n<p><strong>Universal Health Services (UHS)<\/strong> \u2014 Wells Fargo raises its price target to $170.00 from $166.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Vale (VALE)<\/strong> \u2014 Barclays PLC lowers its price target to $14.50 from $15.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Vale (VALE)<\/strong> \u2014 Freedom Broker lowers its price target to $9.50 from $12.00, maintaining a Buy rating.<\/p>\n<p><strong>Vale (VALE)<\/strong> \u2014 UBS lowers its price target to $13.50 from $14.50, maintaining a Neutral rating.<\/p>\n<p><strong>Valero Energy (VLO)<\/strong> \u2014 Morgan Stanley raises its price target to $420.00 from $411.00, maintaining an Equal Weight rating.<\/p>\n<p><strong>Vanda Pharmaceuticals (VNDA)<\/strong> \u2014 HC Wainwright reiterates its Buy rating.<\/p>\n<p><strong>Veralto (VLTO)<\/strong> \u2014 Barclays PLC raises its price target to $129.00 from $117.00, maintaining an Overweight rating.<\/p>\n<p><strong>Veralto (VLTO)<\/strong> \u2014 Citigroup raises its price target to $120.00 from $107.00, maintaining a Neutral rating.<\/p>\n<p><strong>Veralto (VLTO)<\/strong> \u2014 RBC Capital raises its price target to $121.00 from $109.00, maintaining a Sector Perform rating.<\/p>\n<p><strong>Veralto (VLTO)<\/strong> \u2014 Stifel Nicolaus raises its price target to $132.00 from $113.00, maintaining a Buy rating.<\/p>\n<p><strong>Vertiv (VRT)<\/strong> \u2014 Glj Research lowers its price target to $187.00 from $188.00, maintaining a Sell rating.<\/p>\n<p><strong>Vor Biopharma (VOR)<\/strong> \u2014 Stifel Nicolaus sets a $40.00 price target.<\/p>\n<p><strong>Voyager Technologies (VOYG)<\/strong> \u2014 KeyCorp lowers its price target to $40.00 from $50.00, maintaining an Overweight rating.<\/p>\n<p><strong>Vulcan Materials (VMC)<\/strong> \u2014 B. Riley Financial, Inc. raises its price target to $315.00 from $300.00, maintaining a Buy rating.<\/p>\n<p><strong>Vulcan Materials (VMC)<\/strong> \u2014 Stephens raises its price target to $315.00 from $285.00, maintaining an Overweight rating.<\/p>\n<p><strong>Wabash National (WNC)<\/strong> \u2014 DA Davidson upgrades the stock from Hold to Strong-Buy.<\/p>\n<p><strong>Wayfair (W)<\/strong> \u2014 JPMorgan raises its price target to $136.00 from $125.00, maintaining an Overweight rating.<\/p>\n<p><strong>West Pharmaceutical Services (WST)<\/strong> \u2014 Jefferies reiterates its Buy rating with a $475.00 price target.<\/p>\n<p><strong>Weyerhaeuser (WY)<\/strong> \u2014 Canadian Imperial Bank of Commerce lowers its price target to $24.00 from $25.00, maintaining an Outperformer rating.<\/p>\n<p><strong>Weyerhaeuser (WY)<\/strong> \u2014 Citigroup raises its price target to $23.00 from $21.00, maintaining a Buy rating.<\/p>\n<p><strong>Willis Towers Watson Public (WTW)<\/strong> \u2014 Mizuho sets a $370.00 price target.<\/p>\n<p><strong>Willis Towers Watson Public (WTW)<\/strong> \u2014 UBS lowers its price target to $395.00 from $398.00, maintaining a Buy rating.<\/p>\n<p><strong>Willis Towers Watson Public (WTW)<\/strong> \u2014 Wells Fargo lowers its price target to $360.00 from $364.00, maintaining an Overweight rating.<\/p>\n<p><strong>World Kinect (WKC)<\/strong> \u2014 BofA Securities reiterates its Underperform rating.<\/p>\n<p><strong>Xcel Energy (XEL)<\/strong> \u2014 Barclays PLC raises its price target to $94.00 from $85.00, maintaining an Overweight rating.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) Today&#8217;s analyst updates for November 2nd, \u00a0show the clearest optimism in energy and healthcare, with multiple price-target increases for major oil&hellip;<\/p>\n","protected":false},"author":3,"featured_media":76816,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>American Analyst Updates: Nov 2nd, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Nov 2nd, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today&#8217;s analyst updates for November 2nd, \u00a0show the clearest optimism in energy and healthcare, with multiple price-target increases for major oil&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-03T19:26:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-03T20:00:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Stock-Market-Analyst-Updates.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"36 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Nov 2nd, 2026\",\"datePublished\":\"2026-11-03T19:26:00+00:00\",\"dateModified\":\"2026-11-03T20:00:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\"},\"wordCount\":7401,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\",\"name\":\"American Analyst Updates: Nov 2nd, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-11-03T19:26:00+00:00\",\"dateModified\":\"2026-11-03T20:00:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Nov 2nd, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Nov 2nd, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Nov 2nd, 2026","og_description":"Analyst Ratings (USA) Today&#8217;s analyst updates for November 2nd, \u00a0show the clearest optimism in energy and healthcare, with multiple price-target increases for major oil&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-11-03T19:26:00+00:00","article_modified_time":"2026-11-03T20:00:19+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/11\/Stock-Market-Analyst-Updates.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"36 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Nov 2nd, 2026","datePublished":"2026-11-03T19:26:00+00:00","dateModified":"2026-11-03T20:00:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/"},"wordCount":7401,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/","name":"American Analyst Updates: Nov 2nd, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-11-03T19:26:00+00:00","dateModified":"2026-11-03T20:00:19+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-nov-2nd-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Nov 2nd, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76799"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76799\/revisions"}],"predecessor-version":[{"id":76801,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76799\/revisions\/76801"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/76816"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}